Phase 1b Trial of Cereblon-Modulating Agents Iberdomide and CC-99282 Plus R-CHOP in Previously Untreated Aggressive B-Cell LymphomaJason Westin,Alejandro Martin Garcia-Sancho,Marc Hoffmann,Theodoros P. Vassilakopoulos,Su-Peng Yeh,Argyrios Gkasiamis,Poliana Patah,Arpankumar Patel,Ju Li,Grzegorz S. NowakowskiBlood（2022）引用 1|浏览41AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
